Which is considered a complex product for the MiFID appropriateness test?

• A. Shares listed on a stock exchange.
• B. A UCITS fund.
• C. Money market instruments.
• D. CFDs or other derivatives.

Answer: (D)

The key idea here is identifying which financial instrument MiFID treats as complex for the appropriateness assessment. Under MiFID II, when a firm sells or advises on a product to a retail client without a formal advice process, it must check whether the client has sufficient knowledge and experience to understand the product. Complex products are those that are harder to understand or carry risk features that aren’t immediately intuitive.

Derivatives like CFDs have features that make them complex: they involve leverage, which can amplify both gains and losses, payoff profiles that are nonlinear or path-dependent, and risks such as rapid margin calls and liquidity issues. These factors mean many retail investors may not fully grasp the risk/return dynamics without a deeper understanding, so they’re categorized as complex for the purposes of the suitability/appropriateness assessment.

In contrast, shares listed on a stock exchange are straightforward with transparent pricing and direct exposure to corporate performance; UCITS funds are standard collective investments with well-understood structures and daily liquidity in many cases; money market instruments are short-term, highly liquid, and carry relatively simple risk profiles. These are not generally treated as complex for the MiFID appropriateness test.

So the correct choice highlights that CFDs or other derivatives are the complex product in this context.